Paper39337608
An Ingenane-Type Diterpene from Euphorbia kansui Promoted Cell Apoptosis and Macrophage Polarization via the Regulation of PKC Signaling Pathways.
Feng X and 6 others. Int J Mol Sci, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. An Ingenane-Type Diterpene from Euphorbia kansui Promoted Cell Apoptosis and Macrophage Polarization via the Regulation of PKC Signaling Pathways. Papers, record 39337608. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337608
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Ingenane-Type Diterpene from Euphorbia kansui Promoted Cell Apoptosis and Macrophage Polarization via the Regulation of PKC Signaling Pathways.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Euphorbia | Major topic |
| Diterpenes | Major topic |
| Apoptosis | Major topic |
| Macrophages | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Protein Kinase C | |
| RAW 264.7 Cells | |
| Cell Proliferation | |
| Protein Kinase C-delta | |
| MAP Kinase Signaling System |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82073737 | National Natural Science Foundation of China | PubMed | ||
| 22067012 | National Natural Science Foundation of China | PubMed | ||
| 82060737 | National Natural Science Foundation of China | PubMed | ||
| 202301AT070253 | Science and Technology Planning Project of Yunnan Province | PubMed | ||
| 202101AZ07001-030 | Science and Technology Planning Project of Yunnan Province | PubMed | ||
| none | the Key Laboratory of New drugs (Traditional Chinese Medicine) for Respiratory Viral Diseases of Yunnan Province | PubMed | ||
| 202103AC100005 | the Key Project of Research and Development of Yunnan Province | PubMed | ||
| 202302AG050004 | the Key Project of Research and Development of Yunnan Province | PubMed |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31986448 | Ingenane and jatrophane diterpenoids from Euphorbia kansui and their antiproliferative effects. | Phytochemistry | 2020 | https://conductscience.org/library/papers/31986448 | PubMed |
| 2 | 28842560 | Reactivation of HIV-1 from Latency by an Ingenol Derivative from Euphorbia Kansui. | Sci Rep | 2017 | https://conductscience.org/library/papers/28842560 | PubMed |
| 3 | 9677384 | Antisense oligonucleotides targeted against protein kinase Cbeta and CbetaII block 1,25-(OH)2D3-induced differentiation. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9677384 | PubMed |
| 4 | 15845901 | PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. | Blood | 2005 | https://conductscience.org/library/papers/15845901 | PubMed |
| 5 | 36924769 | Macrophages at the interface of the co-evolving cancer ecosystem. | Cell | 2023 | https://conductscience.org/library/papers/36924769 | PubMed |
| 6 | 31931159 | Effect of the vinegar-process on chemical compositions and biological activities of Euphorbia kansui: A review. | J Ethnopharmacol | 2020 | https://conductscience.org/library/papers/31931159 | PubMed |
| 7 | 22069553 | The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity. | Toxins (Basel) | 2010 | https://conductscience.org/library/papers/22069553 | PubMed |
| 8 | 32069845 | Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32069845 | PubMed |
| 9 | 31765764 | Kansuiphorin C and Kansuinin A ameliorate malignant ascites by modulating gut microbiota and related metabolic functions. | J Ethnopharmacol | 2020 | https://conductscience.org/library/papers/31765764 | PubMed |
| 10 | 35637950 | Sublytic C5b-9 Induces CCL3/4 Production and Macrophage Accumulation in Thy-1N Rats via PKC-α/p65/IRF-8 Axis. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/35637950 | PubMed |
| 11 | 38417368 | Diannexin alleviates myocardial ischemia-reperfusion injury by orchestrating cardiomyocyte oxidative damage, macrophage polarization and fibrotic process by TLR4-NF-kB-mediated inactivation of NLRP3 inflammasome. | Int Immunopharmacol | 2024 | https://conductscience.org/library/papers/38417368 | PubMed |
| 12 | 34207286 | The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34207286 | PubMed |
| 13 | 33629797 | Macrophage polarization by phytotherapy in the tumor microenvironment. | Phytother Res | 2021 | https://conductscience.org/library/papers/33629797 | PubMed |
| 14 | 34638650 | Kansuinine A Ameliorates Atherosclerosis and Human Aortic Endothelial Cell Apoptosis by Inhibiting Reactive Oxygen Species Production and Suppressing IKKβ/IκBα/NF-κB Signaling. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638650 | PubMed |
| 15 | 34970275 | Macrophage Polarization and Its Role in Liver Disease. | Front Immunol | 2021 | https://conductscience.org/library/papers/34970275 | PubMed |
| 16 | 38262142 | Gansui Banxia decoction modulates immune-inflammatory homeostasis to ameliorate malignant ascites in rats. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38262142 | PubMed |
| 17 | 36358843 | Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358843 | PubMed |
| 18 | 34015626 | Ingenane and jatrophane-type diterpenoids from Euphorbia kansui with multidrug resistance reversal activity. | Phytochemistry | 2021 | https://conductscience.org/library/papers/34015626 | PubMed |
| 19 | 34638030 | Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT /STAT3/ERK signaling pathways to regulate antitumor immunity in C57bl/6 mice. | Phytomedicine | 2021 | https://conductscience.org/library/papers/34638030 | PubMed |
| 20 | 36581167 | Cell death regulation: A new way for natural products to treat osteoporosis. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/36581167 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653330 | Integrated WGCNA, Network Pharmacology, and UPLC-MS/MS Profiling for Investigating the Antitumor Effects of the Kansui Radix Dichloromethane Fraction Against Renal Cell Carcinoma with Experimental Validation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653330 | PubMed |
| 42385354 | Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers. | Biomed Pharmacother | 2026 | https://conductscience.org/library/papers/42385354 | PubMed |
| 42278406 | Special Issue "Recent Advances of Natural Products in Chemical and Biological Aspects". | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278406 | PubMed |
| 41653356 | Macrophage polarization in hematologic cancers: mechanisms and therapeutic strategies. | Blood Res | 2026 | https://conductscience.org/library/papers/41653356 | PubMed |
| 40999190 | Germacrane and humulane sesquiterpenes from the roots and rhizomes of Valeriana officinalis var. latifolia and their anti-inflammatory and anti-influenza virus activities. | Arch Pharm Res | 2025 | https://conductscience.org/library/papers/40999190 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PRKCD | 5580 | PubTator's text mining | https://conductscience.org/library/genes/5580 | NCBI Gene |
| PRRT2 | 112476 | PubTator's text mining | https://conductscience.org/library/genes/112476 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337608
GET https://conductscience.org/api/papers/v1/39337608/references?page=2